Geron Announces FDA Approval of RYTELO™ (Imetelstat) for Lower-Risk MDS with Transfusion-Dependent Anemia.
Biopharmaceutical Company Announces FDA Approval For MDS Treatment
Biopharmaceutical Company Announces FDA…
Biopharmaceutical Company Announces FDA Approval For MDS Treatment
Geron Announces FDA Approval of RYTELO™ (Imetelstat) for Lower-Risk MDS with Transfusion-Dependent Anemia.